Author: Peter

CVS Health Corp, the No 2 manager of drug benefit plans for U.S. employers and insurers, will wait until a second new cholesterol-lowering drug is approved by regulators before negotiating for price discounts or adding either of the much pricer new drugs to its list of covered medications.

School of Medicine and UNLV co-administer grant to foster research that will improve health...mission is "to increase the quantity, quality, and number of successful NIH grant applications in clinical and translational research." Clinical research studies answer specific health questions. Translational research implements a "bench to bedside" process of applying laboratory knowledge to produce new drugs, devices and treatment options for patients.

GSK confirms it has chosen Bangalore (India)for its sixth production facility in the country,… state of Karnataka has approved a 50-acre tract...for the project, …The £85 million ($132.6 million) plant and warehouse, which is slated to be complete in 2017, is being built in anticipation of growth in sales for areas like gastroenterology and anti-inflammatory medicines.

A revolutionary, high-throughput, robotic platform has been designed that automates and standardizes the process of transforming patient samples into stem cells. This unique platform for the first time gives researchers the scale to look at diverse populations to better understand the underlying causes of disease and create new individually tailored treatments, enabling precision medicine in patient care.

Podcast interview with..David G. Miller, RPh, International Academy of Compounding Pharmacists Executive Vice President, and Jay McEniry, Executive Director, Patients and Physicians for Rx Access...topic is Tricare, and the current issues facing compounding pharmacists, and most importantly, the patients they serve.

Newly reinvented Allergan is looking to women’s health as a core therapeutic area, and millennial women make up a large part of its target audience. So now, it’s rolling out a new campaign focused specifically on reaching that population–and it’s using hashtags, emojis and a purple-haired heroine to do it...#ActuallySheCan

Brands are ditching agencies and bringing digital marketing in-house in bigger numbers than ever, and that includes pharma companies… inability of agencies to break through decades of organizational history to respond to fast-changing needs," Pharma does differ …is generally behind on social is due to regulatory concerns…. this is starting to change,"

Recent actions in support of pharmacy by physician-dominated professional societies signal an increased awareness of the importance of pharmacists on patient care teams—and some pharmacists say those actions could boost provider status efforts.

Amarin won what was being called a First Amendment free speech victory for drugmakers. It got a federal court to say the FDA cannot bar Amarin from discussing off-label use of its fish-oil drug Vascepa for a wider group of patients than it is approved for…not clear how big a victory the ruling will be given it came in a lawsuit Amarin brought against the FDA as a defensive move.

Li Tiantian, a Chinese doctor turned tech entrepreneur, is a leading light of the country’s much-trumpeted healthcare reform drive. His medical networking platform DXY.com …has attracted funding from tech giants … reality is rather different… a lack of support by Beijing and obstacles working with China’s huge, fragmented public healthcare sector...